Results 91 to 100 of about 1,637,046 (206)
Adenosine is an important neuromodulator and neuroprotective molecule, which is produced in the brain as a function of neuronal activity, coupling energy expenditure to energy supply. Under conditions of increased need and reduced availability of energy,
Roman, Viktor +4 more
core +1 more source
Age-related changes in A1 adenosine receptor mediated bradycardia
The impact of age on functional sensitivity to A1-adenosine receptor activation was studied in Langendorff-perfused hearts from young (1-2 mo) and old (12-18 mo) male Wistar rats.
Headrick, JP +2 more
core
Aim Postmortem brain studies offer enormous opportunities to study molecular mechanisms associated with suicide. In the present study, conventional [35S]GTPγS binding assay and its version‐up method ([35S]GTPγS binding/immunoprecipitation assay) were ...
Yuji Odagaki +4 more
doaj +1 more source
ObjectivesThis study aimed to identify critical therapeutic targets and design potent antitumor compounds for breast cancer treatment through an integrated bioinformatics and computational chemistry approach.MethodsWe conducted initial screening and ...
Jian Xu, Xue Li, Yiduo Jia, Yiduo Jia
doaj +1 more source
Agonist-induced desensitization of adenosine A1 and A2 receptors was studied in rat striatum slices maintained in carbo-oxygenated Krebs buffer. Slices were exposed to adenosine analogues (either cyclo-pentyl-adenosine or N-ethyl-carboxamido-adenosine ...
Abbracchio MP +4 more
core
Labelling of A1 and A3 adenosine receptors with the new selective A1 agonist 2'-Me-CCPA
Brain is rich of adenosine receptors. Radiolabelled adenosine receptor agonists such as [3H]N6-cyclohexyladenosine ([3H]CHA) and [3H]phenylisopropyladenosine were largely used for labelling adenosine A1 receptor sites.
AMENTA, Francesco +4 more
core +1 more source
Pantoprazole as a potential repurposed drug targeting the adenosinergic system in esophageal cancer. [PDF]
Simioni A +8 more
europepmc +1 more source
From metabolic intermediary to neurotransmitter: purinergic signaling in neurophysiology and vulnerability of brain circuits. [PDF]
Marques LB +5 more
europepmc +1 more source

